Related references
Note: Only part of the references are listed.Targeting cellular senescence with senotherapeutics: senolytics and senomorphics
Lei Zhang et al.
FEBS JOURNAL (2023)
Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance
Sertac Asa et al.
NUCLEAR MEDICINE COMMUNICATIONS (2023)
First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma
Nils Florian Trautwein et al.
JOURNAL OF NUCLEAR MEDICINE (2023)
Head-to-head evaluation of [18F]FDG and [68 Ga]Ga-DOTA-FAPI-04 PET/CT in recurrent soft tissue sarcoma
Bingxin Gu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Feasibility of glioblastoma tissue response mapping with physiologic BOLD imaging using precise oxygen and carbon dioxide challenge
Vittorio Stumpo et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2022)
Clinical Use of PET/MR in Oncology: An Update
Robert Seifert et al.
SEMINARS IN NUCLEAR MEDICINE (2022)
Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment
Christoph Trautwein et al.
JCI INSIGHT (2022)
Brain partial volume correction with point spreading function reconstruction in high-resolution digital PET: comparison with an MR-based method in FDG imaging
Masanobu Ibaraki et al.
ANNALS OF NUCLEAR MEDICINE (2022)
Comparison of [(68) Ga]Ga-DOTA-FAPI-04 PET/CT and [F-18]FDG PET/CT in colorectal cancer
Halil Komek et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
George A. Prenosil et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Multiplexed imaging in oncology
Chrysafis Andreou et al.
NATURE BIOMEDICAL ENGINEERING (2022)
Whole-body CDS+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial
Laura Kist de Ruijter et al.
NATURE MEDICINE (2022)
Circulating DNA and Liquid Biopsies in the Management of Patients with Cancer
Simon A. Joosse et al.
CANCER RESEARCH (2022)
Images Are Data: Challenges and Opportunities in the Clinical Translation of Radiomics
Wei Mu et al.
CANCER RESEARCH (2022)
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
Alessio Rizzo et al.
PHARMACEUTICALS (2022)
Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment
Iljin Kim et al.
CANCERS (2022)
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, 2 trial
James P. Buteau et al.
LANCET ONCOLOGY (2022)
Senescence and cancer - role and therapeutic opportunities
Clemens A. Schmitt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma
Julia Schmitt et al.
THERANOSTICS (2022)
Exploiting senescence for the treatment of cancer
Liqin Wang et al.
NATURE REVIEWS CANCER (2022)
Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology
Carina Stegmayr et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy
Sanjana Ballal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging
Julia C. Carmona-Bozo et al.
EUROPEAN RADIOLOGY (2021)
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET
Federico Simonetta et al.
CLINICAL CANCER RESEARCH (2021)
The Biological Meaning of Radiomic Features
Michal R. Tomaszewski et al.
RADIOLOGY (2021)
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF CANCER (2021)
68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma
Nader Hirmas et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
Michael S. Hofman et al.
LANCET (2021)
Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer
Julian L. Goggi et al.
MOLECULAR IMAGING AND BIOLOGY (2021)
Radiotherapy of oligometastatic prostate cancer: a systematic review
Paul Rogowski et al.
RADIATION ONCOLOGY (2021)
Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-κB Signaling Pathway
Yang Gao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer
Benjamin L. Maughan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2021)
Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ Cells
Bjoern Traenkle et al.
FRONTIERS IN IMMUNOLOGY (2021)
Cell-programmed nutrient partitioning in the tumour microenvironment
Bradley Reinfeld et al.
NATURE (2021)
Clinical Utility of 18F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis
Emmanouil Alevroudis et al.
CANCERS (2021)
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging
Adrien Holzgreve et al.
FRONTIERS IN ONCOLOGY (2021)
PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports
M. J. M. Uijen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
PET/CT in the Evaluation of Hypoxia for Radiotherapy Planning in Head and Neck Tumors: Systematic Literature Review
Susana Lopes et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2021)
Nanobodies as in vivo, non-invasive, imaging agents
Thibault J. Harmand et al.
RSC CHEMICAL BIOLOGY (2021)
Targeting tumor-associated macrophages to synergize tumor immunotherapy
Xiaonan Xiang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
Johanna Maffey-Steffan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene
Mark A. Sellmyer et al.
MOLECULAR THERAPY (2020)
Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617
Jolanta Kunikowska et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience
Stefan A. Koerber et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Radiotheranostics: a roadmap for future development
Ken Herrmann et al.
LANCET ONCOLOGY (2020)
Therapy-induced senescence - an induced synthetic lethality in liver cancer?
Katharina Wolter et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescence
Bo Zhao et al.
NATURE COMMUNICATIONS (2020)
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk et al.
CANCER CELL (2020)
The PET-Tracer 89Z -Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment
Christoph M. Griessinger et al.
CANCER RESEARCH (2020)
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer
Heiko Schoder et al.
CLINICAL CANCER RESEARCH (2020)
Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy
Thomas Lindner et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Positron Emission Tomography Imaging of Poly-(Adenosine Diphosphate-Ribose) Polymerase 1 Expression in Breast Cancer A Nonrandomized Clinical Trial
Elizabeth S. McDonald et al.
JAMA ONCOLOGY (2020)
Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives
Mir Mohd Faheem et al.
CELL DEATH DISCOVERY (2020)
Spatiotemporal PET Imaging Reveals Differences in CAR-T Tumor Retention in Triple-Negative Breast Cancer Models
Alessia Volpe et al.
MOLECULAR THERAPY (2020)
The tumor microenvironment
Nicole M. Anderson et al.
CURRENT BIOLOGY (2020)
Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions
Morten Busk et al.
SEMINARS IN NUCLEAR MEDICINE (2020)
Quo Vadis, Molecular Imaging?
Jan Grimm et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Non-invasive decision support for NSCLC treatment using PET/CT radiomics
Wei Mu et al.
NATURE COMMUNICATIONS (2020)
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Senescence and the SASP: many therapeutic avenues
Jodie Birch et al.
GENES & DEVELOPMENT (2020)
Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images
Greg Zaharchuk et al.
SEMINARS IN NUCLEAR MEDICINE (2020)
PET imaging of meningioma with 18F-FLT: a predictor of tumour progression
Asma Bashir et al.
BRAIN (2020)
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
Susana Banerjee et al.
ESMO OPEN (2020)
Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive in vivo 18F-FDG-PET
Johannes Schwenck et al.
THERANOSTICS (2020)
68Ga-Labeled Prostate-Specific Membrane Antigen Is a Novel PET/CT Tracer for Imaging of Hepatocellular Carcinoma: A Prospective Pilot Study
Mikhail Kesler et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH
Annasofia Anemone et al.
CANCER AND METASTASIS REVIEWS (2019)
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N. Gide et al.
CANCER CELL (2019)
First Human Imaging Studies with the EXPLORER Total-Body PET Scanner
Ramsey D. Badawi et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Senolytics and senostatics as adjuvant tumour therapy
Susan Short et al.
EBIOMEDICINE (2019)
Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma
Elizabeth R. Butch et al.
CANCER RESEARCH (2019)
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial
Lucia Zanoni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma
Dian Jiao et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
FDG-PET Imaging in Cervical Cancer
Nemi Gandy et al.
SEMINARS IN NUCLEAR MEDICINE (2019)
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Il Minn et al.
SCIENCE ADVANCES (2019)
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Tongyan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
Thomas Langbein et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET)
Asma Bashir et al.
NEURO-ONCOLOGY (2019)
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Cun Wang et al.
NATURE (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
Johannes Griss et al.
NATURE COMMUNICATIONS (2019)
Engineering dendritic cell vaccines to improve cancer immunotherapy
Caleb R. Perez et al.
NATURE COMMUNICATIONS (2019)
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
Martina Sollini et al.
EJNMMI RESEARCH (2019)
Quantification of PET Studies
Adriaan A. Lammertsma
JOURNAL OF NUCLEAR CARDIOLOGY (2019)
The dynamic nature of senescence in cancer
Soyoung Lee et al.
NATURE CELL BIOLOGY (2019)
Molecular landmarks of tumor hypoxia across cancer types
Vinayak Bhandari et al.
NATURE GENETICS (2019)
Advances and perspectives of PARP inhibitors
Ming Yi et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
CD4+ and CD8a+ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models
Lotte K. Kristensen et al.
THERANOSTICS (2019)
The yin and yang of imaging tumor associated macrophages with PET and MRI
Sudip Mukherjee et al.
THERANOSTICS (2019)
Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma
Michael Gerard et al.
FRONTIERS IN MEDICINE (2019)
O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results
Carina Stegmayr et al.
CURRENT RADIOPHARMACEUTICALS (2019)
[18F]FPyGaI: A novel β-galactosidase specific PET tracer for in vivoimaging of tumor senescence
Marcel A. Krueger et al.
CANCER RESEARCH (2019)
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
Laura Keller et al.
NATURE REVIEWS CANCER (2019)
Unmasking senescence: context-dependent effects of SASP in cancer
Douglas V. Faget et al.
NATURE REVIEWS CANCER (2019)
Theranostics in immuno-oncology using nanobody derivatives
Quentin Lecocq et al.
THERANOSTICS (2019)
Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives
Philipp Backhaus et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI
Thomas Pyka et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
The opposing roles of CD4+ T cells in anti-tumour immunity
Tomasz Ahrends et al.
IMMUNOLOGY (2018)
A PET imaging agent for evaluating PARP-1 expression in ovarian cancer
Mehran Makvandi et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Imaging activated T cells predicts response to cancer vaccines
Israt S. Alam et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
Jonathan Strosberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
Thomas Lindner et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
Anastasia Loktev et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Molecular Imaging in Cancer Drug Development
Stijn J. H. Waaijer et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine
Michael R. Weist et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
18F-FAC PET Selectively Images Liver-Infiltrating CD4 and CD8 T Cells in a Mouse Model of Autoimmune Hepatitis
Jessica R. Salas et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
Michael S. Hofman et al.
LANCET ONCOLOGY (2018)
Synthetic lethal therapies for cancer: what's next after PARP inhibitors?
Alan Ashworth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Metastatic Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
Ellen Pure et al.
ONCOGENE (2018)
Linking imaging to omics utilizing image-guided tissue extraction
Jonathan A. Disselhorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
Elodie Melsens et al.
RADIATION ONCOLOGY (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
PET/MRI Hybrid Systems
Julia G. Mannheim et al.
SEMINARS IN NUCLEAR MEDICINE (2018)
Target engagement imaging of PARP inhibitors in small-cell lung cancer
Brandon Carney et al.
NATURE COMMUNICATIONS (2018)
Machine Learning in Medical Imaging
Maryellen L. Giger
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2018)
Simultaneous positron emission tomography and ultrafast ultrasound for hybrid molecular, anatomical and functional imaging
Jean Provost et al.
NATURE BIOMEDICAL ENGINEERING (2018)
IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor Immunotherapy
Heather M. Gibson et al.
CANCER RESEARCH (2018)
Tumour heterogeneity and metastasis at single-cell resolution
Devon A. Lawson et al.
NATURE CELL BIOLOGY (2018)
Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
Frederike Bensch et al.
NATURE MEDICINE (2018)
Artificial intelligence in radiology
Ahmed Hosny et al.
NATURE REVIEWS CANCER (2018)
Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT
Johannes Schwenck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Spectral Clustering Predicts Tumor Tissue Heterogeneity Using Dynamic 18F-FDG PET: A Complement to the Standard Compartmental Modeling Approach
Prateek Katiyar et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
A Novel Unsupervised Segmentation Approach Quantifies Tumor Tissue Populations Using Multiparametric MRI: First Results with Histological Validation
Prateek Katiyar et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
ImmunoPET Imaging of Murine CD4+ T Cells Using Anti-CD4 Cys-Diabody: Effects of Protein Dose on T Cell Function and Imaging
Amanda C. Freise et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence
Roswitha Schumacher-Kuckelkorn et al.
PEDIATRIC BLOOD & CANCER (2017)
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Marco Demaria et al.
CANCER DISCOVERY (2017)
Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells
Mohammad Rashidian et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Molecular Imaging of PARP
Brandon Carney et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
Ahmet Krasniqi et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy
James N. Kochenderfer et al.
MOLECULAR THERAPY (2017)
Advances in neuro-oncology imaging
Karl-Josef Langen et al.
NATURE REVIEWS NEUROLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies
Loren S. Michel et al.
RADIOLOGY (2017)
Positron emission tomography and computed tomographic imaging (PET/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: A systematic review and meta-analysis
Andreas Hallqvist et al.
RADIOTHERAPY AND ONCOLOGY (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
Khun Visith Keu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Total-body imaging: Transforming the role of positron emission tomography
Simon R. Cherry et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Lars Henning Schmidt et al.
PLOS ONE (2017)
Lanthanide-Based T2ex and CEST Complexes Provide Insights into the Design of pH Sensitive MRI Agents
Lei Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response
Benjamin M. Larimer et al.
CANCER RESEARCH (2017)
Implementing Genome-Driven Oncology
David M. Hyman et al.
CELL (2017)
A Population-Based Gaussian Mixture Model Incorporating 18F-FDG PET and Diffusion-Weighted MRI Quantifies Tumor Tissue Classes
Mathew R. Divine et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide
Rebecca E. Conway et al.
ANGIOGENESIS (2016)
Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma
Cady Ploessl et al.
ANNALS OF PHARMACOTHERAPY (2016)
Decoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study
Jennifer Schmitz et al.
CANCER RESEARCH (2016)
18F-FDG PET/CT for Staging and Restaging of Breast Cancer
David Groheux et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Imaging approaches to optimize molecular therapies
Ralph Weissleder et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
Yves Pommier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
PET Tracers Beyond FDG in Prostate Cancer
David M. Schuster et al.
SEMINARS IN NUCLEAR MEDICINE (2016)
Is There Use for FDG-PET in Prostate Cancer?
Hossein Jadvar
SEMINARS IN NUCLEAR MEDICINE (2016)
Effects of erlotinib therapy on [11C]erlotinib uptake in EGFR mutated, advanced NSCLC
Idris Bahce et al.
EJNMMI RESEARCH (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
Muhammad Zaeem Noman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach
Malcolm H. Squires et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
Christopher J. Lord et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness andmetastasis
Chris D. Madsen et al.
EMBO REPORTS (2015)
In Vivo Imaging of Natural Killer Cell Trafficking in Tumors
Filippo Galli et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
Anneleen Blykers et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
Richard Tavare et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Combined PET/MR: A Technology Becomes Mature
Hans F. Wehrl et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
In vivo imaging with antibodies and engineered fragments
Amanda C. Freise et al.
MOLECULAR IMMUNOLOGY (2015)
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
Remi-Martin Laberge et al.
NATURE CELL BIOLOGY (2015)
The accumulation mechanism of the hypoxia imaging probe FMISO by imaging mass spectrometry: possible involvement of low-molecular metabolites
Yukiko Masaki et al.
SCIENTIFIC REPORTS (2015)
Imaging tumour hypoxia with positron emission tomography
I. N. Fleming et al.
BRITISH JOURNAL OF CANCER (2015)
In vivo visualization of prostate-specific membrane antigen in glioblastoma
Johannes Schwenck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment
Sjoukje F. Oosting et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers
Alla Gabriella Wernicke et al.
APMIS (2014)
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Marco Demaria et al.
DEVELOPMENTAL CELL (2014)
Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor
Punit Sharma et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Preclinical and Translational PET/MR Imaging
Hans F. Wehrl et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Cellular senescence: from physiology to pathology
Daniel Munoz-Espin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo
Richard Tavare et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Radiation induces senescence and a bystander effect through metabolic alterations
E-C Liao et al.
CELL DEATH & DISEASE (2014)
Prostate specific membrane antigen produces pro-angiogenic laminin peptides downstream of matrix metalloprotease-2
Rebecca E. Conway et al.
ANGIOGENESIS (2013)
Multimodal Elucidation of Choline Metabolism in a Murine Glioma Model Using Magnetic Resonance Spectroscopy and 11C-Choline Positron Emission Tomography
Hans F. Wehrl et al.
CANCER RESEARCH (2013)
Cisplatin Resistance Associated with PARP Hyperactivation
Judith Michels et al.
CANCER RESEARCH (2013)
Evaluation of 3'-deoxy-3'-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas
Aya Shinomiya et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tamara Tchkonia et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Applications for Preclinical PET/MRI
Martin S. Judenhofer et al.
SEMINARS IN NUCLEAR MEDICINE (2013)
Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
K. Oberg et al.
ANNALS OF ONCOLOGY (2012)
Positron emission tomography molecular imaging for drug development
Paul M. Matthews et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
Kiavash Movahedi et al.
CANCER RESEARCH (2012)
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
Nicholas A. Saunders et al.
EMBO MOLECULAR MEDICINE (2012)
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
N-(4-18F-Fluorobenzoyl)Interleukin-2 for PET of Human-Activated T Lymphocytes
Valentina Di Gialleonardo et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prostate-Specific Membrane Antigen as a Potential Novel Vascular Target for Treatment of Glioblastoma Multiforme
A. Gabriella Wernicke et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2011)
Tumor 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) Uptake by PET Correlates with Thymidine Kinase 1 Expression: Static and Kinetic Analysis of 18F-FLT PET Studies in Lung Tumors
J. S. Brockenbrough et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Assessment of MR Compatibility of a PET Insert Developed for Simultaneous Multiparametric PET/MR Imaging on an Animal System Operating at 7 T
Hans F. Wehrl et al.
MAGNETIC RESONANCE IN MEDICINE (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
F. Navid et al.
CURRENT CANCER DRUG TARGETS (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh et al.
LANCET (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
Combined PET/MRI: one step further in multimodality imaging
Alexander W. Sauter et al.
TRENDS IN MOLECULAR MEDICINE (2010)
A Review of Imaging Agent Development
Eric D. Agdeppa et al.
AAPS JOURNAL (2009)
Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates
Michele Di Mascio et al.
BLOOD (2009)
Melan-A-specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4
Oliver Klein et al.
CLINICAL CANCER RESEARCH (2009)
Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
Kaiyumars B. Contractor et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI
Piet Dirix et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning
Barbara Gehler et al.
RADIATION ONCOLOGY (2009)
New technologies to investigate the brain-gut axis
Abhishek Sharma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Functional Imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (Dota-DPhe1,Tyr3-octreotate) and 18F-FDG
Irfan Kayani et al.
CANCER (2008)
In vivo imaging of mucosal CD4(+) T cells using single photon emission computed tomography in a murine model of colitis
Bittoo Kanwar et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2′-deoxycytidine analog
Caius G. Radu et al.
NATURE MEDICINE (2008)
Simultaneous PET-MRI:: a new approach for functional and morphological imaging
Martin S. Judenhofer et al.
NATURE MEDICINE (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Senescence-associated β-galactosidase is lysosomal β-galactosidase
BY Lee et al.
AGING CELL (2006)
Synthesis and in vivo evaluation of [11C]PJ34, a potential radiotracer for imaging the role of PARP-1 in necrosis
ZD Tu et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Preparation of the hypoxia imaging PET tracer [18F]FAZA:: reaction parameters and automation
G Reischl et al.
APPLIED RADIATION AND ISOTOPES (2005)
Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial
EHS Choy et al.
RHEUMATOLOGY (2002)
Mechanisms of normal and tumor-derived angiogenesis
M Papetti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
The brain-heart axis in the perception of cardiac pain: the elusive link between ischaemia and pain
SD Rosen et al.
ANNALS OF MEDICINE (2000)
Share Paper
